Her-2-neu Expression and Progression Toward Androgen Independence in Human Prostate Cancer

Abstract

Her-2-neu expression appears to increase with progression to androgen independence. Thus, therapeutic targeting of this tyrosine kinase in prostate cancer may be warranted.